Distribution of LDL-C Reduction with Atorvastatin, Rosuvastatin and Simvastatin: A VOYAGER Meta-Analysis

被引：0
|
作者：
Karlson, Bjorn W. [1 ,2 ]
Palmer, Michael K. [3 ]
Nicholls, Stephen J. [4 ]
Lundman, Pia [5 ]
Barter, Philip J. [6 ]
机构：
[1] AstraZeneca, Molndal, Sweden
[2] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, Gothenburg, Sweden
[3] Manchester Metropolitan Univ, Sch Healthcare Sci, Manchester M15 6BH, Lancs, England
[4] Univ Adelaide, South Australian Hlth & Med Res Inst, Adelaide, SA, Australia
[5] Karolinska Inst, Danderyd Hosp, Stockholm, Sweden
[6] Univ New S Wales, Sydney, NSW, Australia
来源：
CARDIOLOGY | 2015年 / 131卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P-06
引用
收藏
页码：26 / 27
页数：2
相关论文
共 50 条
  • [1] Equipotent Effects of Rosuvastatin, Atorvastatin and Simvastatin on LDL-C Reduction: Results from the Voyager Meta-Analysis
    Karlson, Bjorn W.
    Palmer, Michael K.
    Nicholls, Stephen J.
    Lundman, Pia
    Barter, Philip J.
    CARDIOLOGY, 2015, 131 : 20 - 20
  • [2] DOSES OF ROSUVASTATIN, ATORVASTATIN AND SIMVASTATIN INDUCING AN EQUIPOTENT EFFECT ON LDL-C: RESULTS FROM THE VOYAGER META-ANALYSIS
    Karlson, B. W.
    Palmer, M. K.
    Nicholls, S. J.
    Lundman, P.
    Barter, P. J.
    ATHEROSCLEROSIS, 2014, 235 (02) : E35 - E35
  • [3] Doses of rosuvastatin, atorvastatin and simvastatin that induce equal reductions in LDL-C and non-HDL-C: Results from the VOYAGER meta-analysis
    Karlson, Bjorn W.
    Palmer, Michael K.
    Nicholls, Stephen J.
    Lundman, Pia
    Barter, Philip J.
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2016, 23 (07) : 744 - 747
  • [4] VARIABILITY OF LDL-C RESPONSE WITH DIFFERENT DOSES OF SIMVASTATIN, ATORVASTATIN AND ROSUVASTATIN: RESULTS FROM VOYAGER
    Karlson, B. W.
    Palmer, M. K.
    Nicholls, S. J.
    Lundman, P.
    Barter, P. J.
    ATHEROSCLEROSIS, 2014, 235 (02) : E295 - E295
  • [5] Baseline LDL-C and choice and dose of statin as determinants of LDL-C goal achievement: meta-analysis from the VOYAGER database
    Karlson, B. W.
    Nicholls, S. J.
    Lundman, P.
    Barter, P. J.
    Palmer, M. K.
    EUROPEAN HEART JOURNAL, 2011, 32 : 342 - 342
  • [6] SOLAR: Initial rosuvastatin superior to atorvastatin, simvastatin for reaching LDL-C goals in high-risk patients
    不详
    FORMULARY, 2007, 42 (08) : 496 - 496
  • [7] Meta-analysis of Comparative Efficacy of Increasing Dose of Atorvastatin Versus Rosuvastatin Versus Simvastatin on Lowering Levels of Atherogenic Lipids (from VOYAGER)
    Nicholls, Stephen J.
    Brandrup-Wognsen, Gunnar
    Palmer, Mike
    Barter, Philip J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (01): : 69 - 76
  • [8] ATTAINMENT OF THE ANTICIPATED >=50% REDUCTION IN LDL-C IN THE FOUR ACC/AHA GUIDELINES STATIN BENEFIT GROUPS: A VOYAGER META-ANALYSIS
    Karlson, B. W.
    Palmer, M. K.
    Nicholls, S. J.
    Lundman, P.
    Barter, P. J.
    ATHEROSCLEROSIS, 2014, 235 (02) : E11 - E12
  • [9] Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy
    Foody, JoAnne M.
    Toth, Peter P.
    Tomassini, Joanne E.
    Sajjan, Shiva
    Ramey, Dena R.
    Neff, David
    Tershakovec, A. Ndrew M.
    Hu, Henry
    Tunceli, Kaan
    VASCULAR HEALTH AND RISK MANAGEMENT, 2013, 9 : 719 - 727
  • [10] CHANGES IN LDL-C LEVELS AND GOAL ATTAINMENT ASSOCIATED WITH ADDING EZETIMIBE ONTO SIMVASTATIN, ATORVASTATIN AND ROSUVASTATIN COMPARED WITH TITRATING STATINS
    Foody, J. M.
    Toth, P. P.
    Sajjan, S.
    Ramey, D. R.
    Neff, D. R.
    Tershakovec, A. M.
    Hu, H.
    Tomassini, J. E.
    Tunceli, K.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 19 - 19
12345